All In MedTech

Device Trial Radar · NCT06293430

Registry on Luma Vision's VERAFEYE System (ENLIgHT)

Registry on Luma Vision's VERAFEYE System in Catheter Ablation and Left Atrial Appendage Closure Procedures

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Dec 15, 2027

Primary completion

Mar 15, 2028

Study completion Mar 15, 2028

Sponsor

Lead sponsor
LUMA Vision Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Mar 5, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the study is to compile real-world data on the use of the VERAFEYE System in standard of care atrial fibrillation (AF) ablation procedures and left atrial appendage closure (LAAC) procedures.

Conditions

  • Atrial Fibrillation
  • Left Atrial Appendage Closure
  • Atrial Arrhythmia

Interventions

  • VERAFEYE SystemDevice

    VERAFEYE system guidance will be used on all patients undergoing AF ablation and/or LAAC procedures.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Acute procedural success rates during the index procedureTime frame: During the procedure

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.